These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 16909113

  • 1. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.
    Weber RG, Hoischen A, Ehrler M, Zipper P, Kaulich K, Blaschke B, Becker AJ, Weber-Mangal S, Jauch A, Radlwimmer B, Schramm J, Wiestler OD, Lichter P, Reifenberger G.
    Oncogene; 2007 Feb 15; 26(7):1088-97. PubMed ID: 16909113
    [Abstract] [Full Text] [Related]

  • 2. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G.
    Am J Pathol; 2001 Aug 15; 159(2):661-9. PubMed ID: 11485924
    [Abstract] [Full Text] [Related]

  • 3. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS.
    Arch Otolaryngol Head Neck Surg; 2006 Apr 15; 132(4):409-15. PubMed ID: 16618910
    [Abstract] [Full Text] [Related]

  • 4. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA.
    Cancer Lett; 2008 Jun 08; 264(1):145-61. PubMed ID: 18331779
    [Abstract] [Full Text] [Related]

  • 5. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
    Hutter G, Scheubner M, Zimmermann Y, Kalla J, Katzenberger T, Hübler K, Roth S, Hiddemann W, Ott G, Dreyling M.
    Genes Chromosomes Cancer; 2006 Feb 08; 45(2):203-10. PubMed ID: 16258956
    [Abstract] [Full Text] [Related]

  • 6. 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.
    Perrone F, Tamborini E, Dagrada GP, Colombo F, Bonadiman L, Albertini V, Lagonigro MS, Gabanti E, Caramuta S, Greco A, Torre GD, Gronchi A, Pierotti MA, Pilotti S.
    Cancer; 2005 Jul 01; 104(1):159-69. PubMed ID: 15929122
    [Abstract] [Full Text] [Related]

  • 7. Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis.
    Tang S, Luo H, Yu J, Yang D, Shu J.
    Chin Med J (Engl); 2003 Jul 01; 116(7):1083-7. PubMed ID: 12890389
    [Abstract] [Full Text] [Related]

  • 8. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
    Bertin R, Acquaviva C, Mirebeau D, Guidal-Giroux C, Vilmer E, Cavé H.
    Genes Chromosomes Cancer; 2003 May 01; 37(1):44-57. PubMed ID: 12661005
    [Abstract] [Full Text] [Related]

  • 9. p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.
    Perrone F, Tabano S, Colombo F, Dagrada G, Birindelli S, Gronchi A, Colecchia M, Pierotti MA, Pilotti S.
    Clin Cancer Res; 2003 Sep 15; 9(11):4132-8. PubMed ID: 14519636
    [Abstract] [Full Text] [Related]

  • 10. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P, Pairojkul C, Jearanaikoon P, Sripa B, Bhudhisawasdi V, Tantimavanich S, Limpaiboon T.
    Hum Pathol; 2009 Jun 15; 40(6):817-26. PubMed ID: 19200577
    [Abstract] [Full Text] [Related]

  • 11. The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia.
    Faderl S, Estrov Z, Kantarjian HM, Thomas D, Cortes J, Manshouri T, Chan CC, Hays KJ, Pierce S, Albitar M.
    Cytokines Cell Mol Ther; 1999 Sep 15; 5(3):159-63. PubMed ID: 10641574
    [Abstract] [Full Text] [Related]

  • 12. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
    Guney S, Jardin F, Bertrand P, Mareschal S, Parmentier F, Picquenot JM, Tilly H, Bastard C.
    Genes Chromosomes Cancer; 2012 Sep 15; 51(9):858-67. PubMed ID: 22619049
    [Abstract] [Full Text] [Related]

  • 13. Molecular characterization of 9p21 deletions shows a minimal common deleted region removing CDKN2A exon 1 and CDKN2B exon 2 in diffuse large B-cell lymphomas.
    Guney S, Bertrand P, Jardin F, Ruminy P, Kerckaert JP, Tilly H, Bastard C.
    Genes Chromosomes Cancer; 2011 Sep 15; 50(9):715-25. PubMed ID: 21638516
    [Abstract] [Full Text] [Related]

  • 14. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
    Weber A, Langhanki L, Schütz A, Wittekind C, Bootz F, Tannapfel A.
    J Pathol; 2002 Nov 15; 198(3):326-34. PubMed ID: 12375265
    [Abstract] [Full Text] [Related]

  • 15. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas.
    Kaulich K, Blaschke B, Nümann A, von Deimling A, Wiestler OD, Weber RG, Reifenberger G.
    J Neuropathol Exp Neurol; 2002 Dec 15; 61(12):1092-9. PubMed ID: 12484572
    [Abstract] [Full Text] [Related]

  • 16. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.
    Kim M, Yim SH, Cho NS, Kang SH, Ko DH, Oh B, Kim TY, Min HJ, She CJ, Kang HJ, Shin HY, Ahn HS, Yoon SS, Kim BK, Shin HR, Han KS, Cho HI, Lee DS.
    Cancer Genet Cytogenet; 2009 Nov 15; 195(1):59-65. PubMed ID: 19837270
    [Abstract] [Full Text] [Related]

  • 17. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas.
    Kaune KM, Neumann C, Hallermann C, Haller F, Schön MP, Middel P.
    Exp Dermatol; 2011 Apr 15; 20(4):331-5. PubMed ID: 21410763
    [Abstract] [Full Text] [Related]

  • 18. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.
    Schmid M, Sen M, Rosenbach MD, Carrera CJ, Friedman H, Carson DA.
    Oncogene; 2000 Nov 23; 19(50):5747-54. PubMed ID: 11126361
    [Abstract] [Full Text] [Related]

  • 19. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P, Zaravinos A, Zioga M, Spandidos DA.
    Br J Dermatol; 2009 Jun 23; 160(6):1215-21. PubMed ID: 19298278
    [Abstract] [Full Text] [Related]

  • 20. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
    Holdt LM, Sass K, Gäbel G, Bergert H, Thiery J, Teupser D.
    Atherosclerosis; 2011 Feb 23; 214(2):264-70. PubMed ID: 20637465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.